UGOCHI MADUBUIKE: Open Payments
NPI 1508414954 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 25 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $596
Food & beverage: $545Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $161 |
| Janssen Biotech, Inc. | 5 | $112 |
| Madrigal Pharmaceuticals | 2 | $63 |
| Gilead Sciences, Inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $21 |
| ORPHALAN INC | 1 | $16 |
Products named: TREMFYA, SKYRIZI, REZDIFFRA, CREON, ENTYVIO, XIFAXAN, IQIRVO, RINVOQ.
Industry payments across GA — which companies pay providers there.
